My Research
In my research I work with a plant known as Artemisia annua. This plant is the sole biological source for the active anti-malarial drug qing hao su (ching-how-soo), or, artemisinin, as it is known outside of China. At times, limitations to the availability and accessibility of this drug threatens the prevention and treatment of malaria. One of these limitations is that A. annua does not produce artemisinin in high or uniform quantities. Thus, research on metabolic engineering, like the kind done in my lab (Deyu Xie, North Carolina State University) is important for establishing plant cultivars capable of producing high levels of artemisinin.
The primary mechanism behind these enzyme interactions is an electron transfer from one enzyme to the next. Electron transfers can introduce bottlenecks into a biosynthetic pathway, especially if they are inefficient (enzymes do not partner effectively, or electrons are consumed by other co-factors/enzymes). Thus, uncovering the intricacies of enzyme partnerships such as that between CYP71AV1 and CPRs/CYB5 will be invaluable to the advancement of metabolic engineering. My research intends to interrogate the specificities of the partnership between CYP71AV1 and its redox enzymes to generate important kinetic and thermodynamic data that will inform metabolic engineering strategies.